Literature DB >> 19408354

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD).

Sam Egger1, Kathy Petoumenos, Adeeba Kamarulzaman, Jennifer Hoy, Somnuek Sungkanuparph, John Chuah, Kathleen Falster, Jialun Zhou, Matthew G Law.   

Abstract

BACKGROUND: Random effects models were used to explore how the shape of CD4 cell count responses after commencing combination antiretroviral therapy (cART) develop over time and, in particular, the role of baseline and follow-up covariates.
METHODS: Patients in Asia Pacific HIV Observational Database who first commenced cART after January 1, 1997, and who had a baseline CD4 cell count and viral load measure and at least 1 follow-up measure between 6 and 24 months, were included. CD4 cell counts were determined at every 6-month period after the commencement of cART for up to 6 years.
RESULTS: A total of 1638 patients fulfilled the inclusion criteria with a median follow-up time of 58 months. Lower post-cART mean CD4 cell counts were found to be associated with increasing age (P < 0.001), pre-cART hepatitis C coinfection (P = 0.038), prior AIDS (P = 0.019), baseline viral load < or equal to 100,000 copies per milliliter (P < 0.001), and the Asia Pacific region compared with Australia (P = 0.005). A highly significant 3-way interaction between the effects of time, baseline CD4 cell count, and post-cART viral burden (P < 0.0001) was demonstrated. Higher long-term mean CD4 cell counts were associated with lower baseline CD4 cell count and consistently undetectable viral loads. Among patients with consistently detectable viral load, CD4 cell counts seemed to converge for all baseline CD4 levels.
CONCLUSIONS: Our analysis suggest that the long-term shape of post-cART CD4 cell count changes depends only on a 3-way interaction between baseline CD4 cell count, viral load response, and time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408354      PMCID: PMC2752681          DOI: 10.1097/qai.0b013e31819906d3

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  41 in total

1.  Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.

Authors:  G R Kaufmann; M Bloch; J J Zaunders; D Smith; D A Cooper
Journal:  AIDS       Date:  2000-05-26       Impact factor: 4.177

2.  Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy.

Authors:  P M Tarwater; J B Margolick; J Jin; J P Phair; R Detels; C Rinaldo; J Giorgi; A Muñoz
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

3.  Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.

Authors:  T E Yamashita; J P Phair; A Muñoz; J B Margolick; R Detels; S J O'Brien; J W Mellors; S M Wolinsky; L P Jacobson
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

4.  Contrasting quantitative alterations in CD4+ and CD8+ lymphocytes in HIV-infected African Americans compared with the Caucasian population.

Authors:  J M Cruse; M N Brackin; R E Lewis; B T Brackin
Journal:  Pathol Immunopathol Res       Date:  1989

5.  Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Authors:  Gilbert R Kaufmann; Hansjakob Furrer; Bruno Ledergerber; Luc Perrin; Milos Opravil; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Martin Rickenbach; Bernard Hirschel; Manuel Battegay
Journal:  Clin Infect Dis       Date:  2005-06-24       Impact factor: 9.079

6.  HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

Authors:  A N Phillips; S Staszewski; R Weber; O Kirk; P Francioli; V Miller; P Vernazza; J D Lundgren; B Ledergerber
Journal:  JAMA       Date:  2001-11-28       Impact factor: 56.272

7.  Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.

Authors:  Vincent Le Moing; Rodolphe Thiébaut; Geneviève Chêne; Catherine Leport; Valérie Cailleton; Christian Michelet; Hervé Fleury; Serge Herson; François Raffi
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

8.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

9.  Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

Authors:  Peter W Hunt; Steven G Deeks; Benigno Rodriguez; Hernan Valdez; Starley B Shade; Donald I Abrams; Mari M Kitahata; Melissa Krone; Torsten B Neilands; Richard J Brand; Michael M Lederman; Jeffrey N Martin
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

10.  Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).

Authors:  Preeyaporn Srasuebkul; Alexandra Calmy; Jialun Zhou; Nagalingeswaran Kumarasamy; Matthew Law; Poh Lian Lim
Journal:  AIDS Res Ther       Date:  2007-09-17       Impact factor: 2.250

View more
  26 in total

1.  In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.

Authors:  Mariana Leão de Lima-Stein; Wagner Tadeu Alkmim; Maria Clara de Souza Bizinoto; Luis Fernandez Lopez; Marcelo Nascimento Burattini; Juliana Terzi Maricato; Leila Giron; Maria Cecília Araripe Sucupira; Ricardo Sobhie Diaz; Luiz Mario Janini
Journal:  AIDS Res Hum Retroviruses       Date:  2014-08-25       Impact factor: 2.205

2.  HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).

Authors:  N Han; S T Wright; C C O'Connor; J Hoy; S Ponnampalavanar; M Grotowski; H X Zhao; A Kamarulzaman
Journal:  HIV Med       Date:  2014-11-18       Impact factor: 3.180

3.  CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts.

Authors:  Stephen T Wright; Andrew Carr; Ian Woolley; Michelle Giles; Jennifer Hoy; David A Cooper; Matthew G Law
Journal:  J Acquir Immune Defic Syndr       Date:  2011-09-01       Impact factor: 3.731

4.  The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting.

Authors:  Alana T Brennan; Mhairi Maskew; Ian Sanne; Matthew P Fox
Journal:  Trop Med Int Health       Date:  2013-02-18       Impact factor: 2.622

5.  High rates of tuberculosis in patients accessing HAART in rural South Africa.

Authors:  Kogieleum Naidoo; Quarraisha Abdool Karim; Ambika Bhushan; Kasavan Naidoo; Nonhlanhla Yende-Zuma; Patricia K McHunu; Janet Frohlich; Farina Karim; Michele Upfold; Paul Kocheleff; Salim S Abdool Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

6.  CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy.

Authors:  Kathy Petoumenos; Jun Yong Choi; Jennifer Hoy; Sasisopin Kiertiburanakul; Oon Tek Ng; Mark Boyd; Reena Rajasuriar; Matthew Law
Journal:  Antivir Ther       Date:  2017

7.  The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHOD.

Authors:  Amit C Achhra; Jialun Zhou; Jun Yong Choi; Jennifer Hoy; Fujie Zhang; David J Templeton; Tuti Merati; Ian Woolley; Kathy Petoumenos; Janaki Amin
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2011-04-20

8.  Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience.

Authors:  S T Wright; K Petoumenos; M Boyd; A Carr; S Downing; C C O'Connor; M Grotowski; M G Law
Journal:  HIV Med       Date:  2012-10-04       Impact factor: 3.180

9.  Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Authors:  Sabine M Hermans; Agnes N Kiragga; Petra Schaefer; Andrew Kambugu; Andy I M Hoepelman; Yukari C Manabe
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

10.  The immunological response of HIV-positive patients initiating HAART at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Authors:  L Annison; A Dompreh; Y Adu-Sarkodie
Journal:  Ghana Med J       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.